What is DeepTek?
DeepTek operates at the intersection of medical technology and artificial intelligence, specializing in assisted and augmented imaging-focused algorithmic tools. By leveraging deep learning models to analyze radiographs, CT scans, and MRI data, the company provides radiologists and physicians with high-precision diagnostic support. Its core value proposition lies in enhancing clinical efficiency and diagnostic accuracy, thereby reducing the cognitive burden on healthcare providers. As a leader in the healthtech sector, DeepTek is transforming the standard of care by digitizing the radiology pipeline and ensuring that imaging experts have access to cutting-edge, automated analysis tools that facilitate faster patient outcomes.
How much funding has DeepTek raised?
DeepTek has raised a total of $10M across 1 funding round:
Other Financing Round
$10M
Other Financing Round (2022): $10M with participation from Tata Capital Healthcare Fund II
Key Investors in DeepTek
Tata Capital Healthcare Fund II
A specialized investment vehicle focused on the healthcare and life sciences sector, providing growth capital to companies driving innovation in medical technology and clinical services.
What's next for DeepTek?
With this major strategic investment, DeepTek is poised to transition from a specialized developer to a dominant force in the global medical imaging market. The company is expected to prioritize the expansion of its algorithmic suite, focusing on broader clinical applications and deeper integration with existing hospital information systems. By scaling its infrastructure, DeepTek aims to address the increasing demand for automated diagnostic support in high-volume clinical environments. Future growth will likely center on international market penetration and the continuous refinement of its proprietary AI models to maintain a competitive edge in the rapidly evolving landscape of digital health and diagnostic automation.
See full DeepTek company page
